Vaccines

The Vaccine Development Program is focused on the development of a sustainable and cost-effective vaccine for preventing diseases caused by two widespread neglected tropical diseases (NTDs) – hookworm and schistosomiasis. The HHVI is the first-ever initiative developing a sustainable and cost-effective vaccine to combat hookworm, which globally infects 576 million people. Schistosomiasis infects over 200 million people around the world and is the deadliest disease of the seven most prevalent NTDs, killing an estimated 280,000 people annually. Both are highly infectious parasitic diseases that severely threaten vulnerable populations in the most impoverished areas around the world.